4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001231919-26-000300
Director bought 369,000 shares at an average $23.75 ($8,762,797)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-03-27 | Purchase | +310,700 | $23.67 | $7,354,269 | 5,767,221 | I: show line 1 in the form |
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-03-30 | Purchase | +58,300 | $24.16 | $1,408,528 | 5,825,521 | I: show line 2 in the form |
| Open-market purchases · 369,000 sh · avg $23.75 · $8,762,797 | |||||||
Loading xslF345X06/form4-03312026_040301.xml…